ENTX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 15:39):

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs...

Stats
Dagens volum	2 948.00
Gjennomsnittsvolum	233 156
Markedsverdi	70.26M
EPS	$0 ( 2024-03-29 )
Neste inntjeningsdato	( $-0.0600 ) 2024-05-03
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.39
ATR14	$0.00800 (0.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Yaacov-garbeli Dana	Buy	130 000	Stock Option (right to buy)
2024-04-19	Yaacov-garbeli Dana	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-04-19	Galitzer Hillel	Buy	130 000	Stock Option (right to buy)
2024-04-19	Galitzer Hillel	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-01-12	Taitel Haya	Buy	9 500	Ordinary Shares, par value NIS 0.0000769 per share

INSIDER POWER
100.00
Last 93 transactions
Buy: 4 653 836 \| Sell: 4 161 674

Volum Korrelasjon

Lang: -0.58 (weak negative)

Kort: 0.05 (neutral)

Signal:(48.659) Neutral

Entera Bio Ltd Korrelasjon

10 Mest positive korrelasjoner
TITN	0.854
TBLA	0.849
OPNT	0.84
OFIX	0.838
NAVI	0.835
LCAA	0.834
ATEC	0.831
ALSA	0.828
WDAY	0.827
GLLI	0.825

10 Mest negative korrelasjoner
AVO	-0.847
BLIN	-0.845
GETVV	-0.84
GLUE	-0.839
SIDU	-0.837
ATAI	-0.824
BIMI	-0.819
CEG	-0.816
DRUG	-0.814
GPOR	-0.813

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Entera Bio Ltd Korrelasjon - Valuta/Råvare

0.09
( neutral )

0.00
( neutral )

0.55
( weak )

-0.12
( neutral )

Entera Bio Ltd Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2023
Omsetning:	$0
Bruttogevinst:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2022
Omsetning:	$134 000
Bruttogevinst:	$33 000.00 (24.63 %)
EPS:	$-0.450

FY	2021
Omsetning:	$571 000
Bruttogevinst:	$198 000 (34.68 %)
EPS:	$0.425

Financial Reports:

No articles found.

Entera Bio Ltd

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.

Sanntidsoppdatering for Entera Bio Ltd [ENTX]

Upcoming Earnings Alert